Found: 6
Select item for more details and to access through your institution.
A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE.
- Published in:
- Rheumatology, 2020, v. 59, n. 10, p. 2734, doi. 10.1093/rheumatology/kez623
- By:
- Publication type:
- Article
Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 8, p. 1474, doi. 10.1093/ndt/gfaa117
- By:
- Publication type:
- Article
PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 8, p. 1408, doi. 10.1093/ndt/gfaa066
- By:
- Publication type:
- Article
Intrinsically Distinct Role of Neutrophil Extracellular Trap Formation in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Compared to Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 12, p. 2047, doi. 10.1002/art.41047
- By:
- Publication type:
- Article
The role of programmed cell death-1 (PD-1) and its ligands in pediatric cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.566732
- By:
- Publication type:
- Article